Keywords: minster, l0, 7m, loss, line, expectations, uk
Minster's L0.7M loss in line with expectations
Article | 19 December 2005
The UK's Minster Pharmaceuticals, a specialist in psychiatric and neurological disorders, has posted a pretax loss of L705,000 ($1.2 million), in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
